卵清蛋白(OVA)是鸡蛋清中的主要蛋白成分,是一种大而复杂的糖蛋白,能够引起机体适度的免疫性。因此,卵清蛋白(OVA)被作为抗原广泛用于免疫实验中。 规格:25 mg 编号:LET0027、LET0028 冻干,不含盐 内毒素水平:<0.1 EU/mg 纯度:>98%蛋白质 分子量:~45kDa 来源:鸡蛋清 CAS编号:9006–59–1 同义词:Plakalbumin,Allergen Gal dII 卵清蛋白(OVA)特点: 很多卵清蛋白常被内毒素污染,从而导致伪影和不准确的结果。 卵清蛋白(OVA)不含内毒素,保证内毒素水平(LPS)低于0.1 EU/mg。由LIONEX GmbH在德国制造。 卵清蛋白(OVA)部分文献应用: 1、Baumann D, H?gele T, Mochayedi J, Drebant J, Vent C, Blobner S, Noll JH, Nickel I, Schumacher C, Boos SL, Daniel AS, Wendler S, Volkmar M, Strobel O, Offringa R. Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy. Nat Commun. 2020 May 1;11(1):2176. doi: 10.1038/s41467-020-15979-2. 2、Martí i Líndez AA, Dunand-Sauthier I, Conti M, Gobet F, Nú?ez N, Hannich JT, Riezman H, Geiger R, Piersigilli A, Hahn K, Lemeille S, Becher B, De Smedt T, Hugues S, Reith W. Mitochondrial arginase-2 is a cellautonomous regulator of CD8+ T cell function and antitumor efficacy. JCI Insight. 2019 Nov 21;4(24):e132975. doi: 10.1172/jci.insight.132975. 3、Yoshida S, Shime H, Matsumoto M, Kasahara M, Seya T. Anti-oxidative Amino Acid L-ergothioneine Modulates the Tumor Microenvironment to Facilitate Adjuvant Vaccine Immunotherapy. Front Immunol. 2019 Apr 4;10:671. doi: 10.3389/fimmu.2019.00671. |
|